Results 181 to 190 of about 2,444,578 (297)

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

African Vaccination Week as a catalyst for integrated services and immunisation equity: synthesis of implementation insights from countries in the WHO African Region

BMJ Public Health
Charles Shey Wiysonge, Sarah Wanyoike, Aschalew Teka Bekele, Crépin H Dadjo, Patricia E M Manga, Ado Mpia Bwaka, Yolande Vou Masembe   +6 more
doaj   +1 more source

Finding the Gaps: Integrated Serosurveillance and Spatial Clustering of Vaccine Preventable Diseases in Samoa, 2018-2019. [PDF]

Trop Med Infect Dis
Ward S, Lawford HLS, Sartorius B, Mayfield HJ, Amosa-Lei Sam F, Sheridan SL, Thomsen R, Viali S, Lau CL.   +8 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

The impact of medication shortages on paediatric care: A retrospective impact analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Medication shortages are a growing global concern, with potentially greater consequences in paediatric patients because of the limited availability of safe, evidence‐based and appropriately formulated medication. This study aimed to evaluate the impact of medication shortages on paediatric patients by assessing the suitability and safety of ...
Maaike Johanna Rutten ‐ van Kranenburg, Laurens Christiaan van Rijn, Elisabeth Johanna Ruijgrok, Sinno Henricus Paulus Simons, Brigitta Carolina Maria Witjes, Jan‐Dietert Christoffer Brugma, Robert Bernard Flint   +6 more
wiley   +1 more source

Geographic and age-specific trends in vaccine-preventable diseases in Qatar: A primary health care-based study (2021-2024). [PDF]

Qatar Med J
Bakri AOH, Al-Kuwari MG, Elbourdiny AAM, Al-Shamali MHMA, Al-Romaihi HEHR.   +4 more
europepmc   +1 more source

Vaccine hesitancy and bone health: Musculoskeletal sequelae of vaccine-preventable diseases. [PDF]

Osteoporos Sarcopenia
Shabbir R, Shabbir Z, Parente PEL, Azad A.   +3 more
europepmc   +1 more source

Capacity building in medicines development and regulation in Africa—Overview on recent progress

British Journal of Clinical Pharmacology, EarlyView.
Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke, Emile Malan, Michael Reid, Patrick Bouic, Haylene Nell, Goonaseelan Pillai, Catriona Waitt, Bernd Rosenkranz   +7 more
wiley   +1 more source

Investigation of the sero-epidemiology of vaccine preventable diseases and common viral infections in French populations. [PDF]

Commun Med (Lond)
Bloch E, Baudemont G, Donnadieu F, Garcia L, Pelleau S, SeroPed Study Consortium, Milieu Intérieur Consortium, Quintana-Murci L, Duffy D, Fontanet A, White M.   +10 more
europepmc   +1 more source

Lithium‐related adverse drug reactions in children: A case–control study comparing lithium to second‐generation antipsychotics in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling, Ravish N. Gangapersad, Lillian Lieuw, Patrick C. Souverein, Eibert R. Heerdink, Pilar Garcia‐Gomez, Manon H. J. Hillegers, Birgit C. P. Koch, Bram Dierckx   +8 more
wiley   +1 more source